Get the latest news on MedMira stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on MMIRF performance

Latest MedMira Stock News | OTC:MMIRF | Benzinga

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

News

Intraday Update

Markets

Movers

Trading Ideas

ACHN

ADSW

AHPI

ARXRF

ASNB

BCOW

BTBIF

CBCFF

CBLI

CGEN

CSBTF

CTLT

DEAC

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

EVRG

FCPT

FTMNF

GCFFF

GJNSY

GLGDF

GVDNY

HBAYF

HTCMF

LAKE

LAND

LGDOF

LGDTF

LLIT

LYTS

Blackrock Muniholdings Investment Quality Fund

Blackrock Muniholdings New York Quality Fund

MITEY

Blackrock Muniyield Michigan Quality Fund

MMIRF

Blackrock Muniyield Pennsylvania Quality Fund

MRNTF

Blackrock Muniholdings California Quality Fund

Blackrock Muniyield New York Quality Fund

Nuveen Insured Tax-Free Advantage Municipal Fund

Nuveen Insured New York Tax-Free Advantage Municipal Fund

NVRO

Nuveen New Jersey Dividend Advantage Municipal Fund

OCPNY

OPYGY

PCYO

PLHCF

POYYF

QIFTF

QMCO

QTRHF

RWNFF

SNPHF

SPFI

TGLVY

TPRFF

VCNX

WFCF

WOSSF

XPPLF

MZEIQ

ALTKF

PHYS

NNVC

PSTO

FPWM

Stocks That Hit 52-Week Highs On Monday

Movers & Shakers

General

AGHC

ANGI

ASCOT RESOURCES LTD by Ascot Resources Ltd.

AOTVF

ASDZF

ARTEMIS THERAPEUTICS INC by Artemis Therapeutics, Inc.

ATMS

BIG BLOCKCHAIN INTELGNCE by Big Blockchain Intelligence Group Inc.

BBKCF

BFALL

BSPK

BYZN

CCSB

CELLCUBE ENERGY STORAGE by Cellcube Energy Storage Sys Inc.

CECBF

CEFC

CHDGF

China TechFaith Wirelessmmunication Technology

CNTF

COFOL

CTIB

CYIG

DFMTF

DMNKF

DPLS

EOPT

ESTR

FLES

FRLI

FTPLF

FTXP

FUAPF

FUTL

GAXY

GBHPF

HQGE

HSKA

HTGM

INQD

INSYQ

IPNFF

IRIX

ISWH

IVITF

JINFF

MCIG

MRSN

MXROF

MYOV

NABIF

NOHO

NRBT

OPMZ

OXBDF

OZSC

PDLI

PDNLA

PHVAF

PTVL

QMC QUANTUM MINERALS CORP by QMC Quantum Minerals Corp.

QMCQF

REGEN BIOPHARMA INC PFD by Regen Biopharma, Inc.

RGBPP

RTNB

RTTR

SAMMF

SHGXY

SNAVF

SPLIF

STKXF

SYHBF

SZBI

TBEV

TRIB

TTNP

TUSK

TWOH

VIDA

VLRX

VRME

VVCIF

VYEY

WMLLF

FRFFF

UNJCF

GRDZF

DGTLF

BRTZF

SDXEF

SDPI

POROF

BFARF

SCYYF

NVLPF

GEEPF

GAYGF

GTARF

Stocks That Hit 52-Week Lows On Friday

MedMira Inc

Press Releases

Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada

MedMira Announces the appointment of Vice President of Commercial Operations

MedMira Reports FY2024 Fourth Quarter and Year End Financial Results

Legal

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

Earnings

MedMira Reports First Quarter Results FY2025

MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test

MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use

MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

Contracts

MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada

MedMira Announces Partnership with MediGroup Physician Services in the United States

TSXV:MIR

MedMira

Comments

MedMira Stock News

News

Latest MedMira Stock News | OTC:MMIRF | Benzinga

Monday, January 27, 2020

Friday, September 13, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga